Punita Ponda, MD
Allergy & Immunology · Bronx, NYNPI 1396838934
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,194 of the $4,700 with a category attached, or 89.2%. Regeneron accounts for 89.2% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $4,338 and has fallen 99.5% since, to $20 in 2025.
Across 24 payments — averaging $195.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$4K
- Takeda Pharmaceuticals U.S.A., Inc.$184
- Pharming Healthcare, Inc.$114
- GSK$88
- Genentech USA, Inc.$38
- Shire North American Group Inc$34
- plus $48 from 3 others
Across 111 payments — averaging $5668.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$278K
- Novartis$260K
- GSK$49K
- Aimmune Therapeutics, Inc.$36K
- Alk-abello, Inc$6K
What the payments were for
- Consulting fees$4,19489%
- Food & beverage$50611%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 2 | $4,194 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $184 |
| Pharming Healthcare, Inc. | 1 | $114 |
| GSK | 4 | $88 |
| Genentech USA, Inc. | 2 | $38 |
| Shire North American Group Inc | 2 | $34 |
| CSL Behring | 1 | $17 |
| Grifols USA, LLC | 1 | $16 |
| Alk-abello, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,700 in reported general payments places this provider in the 60th percentile of 320 allergy & immunology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Bronx
- Tania ElliottBronx$43K
- Golda HudesBronx$29K
- Ujwala KazaNew York$1.1M
- Syed MustafaRochester$948K
- Robert SporterNew York$946K
- Gregory PuglisiPlainview$813K
- Stanley GoldsteinRockville Centre$643K
- Robert TamayevRego Park$321K
- Richard InselNew York$269K
- Payel GuptaBrooklyn$256K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.